OTCMKTS:ELXMF Nova Eye Medical (ELXMF) Stock Price, News & Analysis $0.10 0.00 (0.00%) As of 09/11/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Nova Eye Medical Stock (OTCMKTS:ELXMF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Nova Eye Medical alerts:Sign Up Key Stats Today's Range$0.10▼$0.1050-Day Range$0.10▼$0.1052-Week Range$0.10▼$0.19VolumeN/AAverage Volume75,600 shsMarket CapitalizationN/AP/E Ratio13.70Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Nova Eye Medical (OTCMKTS: ELXMF) is a medical device company focused on developing advanced ophthalmic diagnostic solutions for ocular surface diseases, particularly dry eye. Its flagship Ocular Surface Analyzer integrates high-resolution imaging with proprietary algorithms to provide quantitative assessments of tear film stability, lipid layer thickness and meibomian gland function. By offering objective, reproducible data, the system is designed to support eye care professionals in early detection and accurate diagnosis of dry eye disease. The Nova Eye Medical platform combines specialized hardware and custom software to automate key measurements such as non-invasive tear breakup time, tear meniscus height and meibography. Automated image analysis and report generation streamline clinical workflows, enabling practitioners to monitor treatment efficacy and adjust therapeutic strategies based on precise ocular surface metrics. The company continues to refine its software suite to expand diagnostic capabilities and enhance user experience. Nova Eye Medical distributes its products through a network of direct sales and third-party distributors in North America and select European markets. With an emphasis on personalized treatment monitoring and early intervention, the company aims to address the growing global demand for objective ocular surface diagnostics. Management comprises industry professionals with backgrounds in ophthalmic instrumentation, regulatory affairs and device commercialization as Nova Eye Medical pursues broader clinical adoption.AI Generated. May Contain Errors. Read More Receive ELXMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nova Eye Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELXMF Stock News HeadlinesNova Eye Medical Achieves Record FY25 Revenue with Strong US GrowthAugust 27, 2025 | msn.comNova Eye Medical Director Increases ShareholdingAugust 5, 2025 | tipranks.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.September 12 at 2:00 AM | Brownstone Research (Ad)Nova Eye Medical Hosts Investor Webinar to Discuss Ophthalmic InnovationsJuly 7, 2025 | tipranks.comNova Eye Medical Achieves Record Revenues in FY25July 7, 2025 | tipranks.comNova Eye Medical to Quote New Securities on ASXMay 4, 2025 | tipranks.comNova Eye Medical Reports Record Sales and Identifies New Growth OpportunitiesApril 28, 2025 | tipranks.comNova Eye Medical Issues New Securities Under Employee Incentive SchemeMarch 28, 2025 | tipranks.comSee More Headlines ELXMF Stock Analysis - Frequently Asked Questions How have ELXMF shares performed this year? Nova Eye Medical's stock was trading at $0.10 at the start of the year. Since then, ELXMF shares have increased by 0.0% and is now trading at $0.10. How do I buy shares of Nova Eye Medical? Shares of ELXMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:ELXMF CIKN/A Webwww.ellex.com Phone61 8 7074 8200FaxN/AEmployees301Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio13.70 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTCMKTS:ELXMF) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | SponsoredElon’s new AI play could hand regular Americans a Tesla‑like paydayElon Musk just launched his boldest AI project yet... And if history is any guide — it could make early inv...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nova Eye Medical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Nova Eye Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.